Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Interest & Investment Income (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Interest & Investment Income for 2 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 104.56% to $1.8 million in Q4 2025 year-over-year; TTM through Oct 2025 was $6.2 million, a N/A change, with the full-year FY2025 number at $3.2 million, changed N/A from a year prior.
  • Interest & Investment Income was $1.8 million for Q4 2025 at Kestra Medical Technologies, down from $2.2 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.2 million in Q3 2025 to a low of $37000.0 in Q3 2024.